1NKK image
Deposition Date 2003-01-03
Release Date 2003-02-11
Last Version Date 2021-10-27
Entry Detail
PDB ID:
1NKK
Title:
COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein P40
Gene (Uniprot):UL80
Mutagens:A143Q, E31R
Chain IDs:A, B, C, D
Chain Length:256
Number of Molecules:4
Biological Source:Human herpesvirus 5
Polymer Type:polypeptide(L)
Molecule:Peptidomimetic inhibitor
Chain IDs:E, F, G, H
Chain Length:6
Number of Molecules:4
Biological Source:
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
DMH E ASN N4,N4-DIMETHYL-ASPARAGINE
DMK E ASP 3,3-DIMETHYL ASPARTIC ACID
Peptide-like Molecules
PRD_000405
Primary Citation
Structural and Biochemical Studies of Inhibitor Binding to Human Cytomegalovirus Protease
Biochemistry 42 885 891 (2003)
PMID: 12549906 DOI: 10.1021/bi027045s

Abstact

Herpesvirus protease is required for the life cycle of the virus and is an attractive target for the design and development of new anti-herpes agents. The protease belongs to a new class of serine proteases, with a novel backbone fold and a unique Ser-His-His catalytic triad. Here we report the crystal structures of human cytomegalovirus protease in complex with two peptidomimetic inhibitors. The structures reveal a new hydrogen-bonding interaction between the main chain carbonyl of the P(5) residue and the main chain amide of amino acid 137 of the protease, which is important for the binding affinity of the inhibitor. Conformational flexibility was observed in the S(3) pocket of the enzyme, and this is supported by our characterization of several mutants in this pocket. One of the structures is at 2.5 A resolution, allowing us for the first time to locate ordered solvent molecules in the inhibitor complex. The presence of two solvent molecules in the active site may have implications for the design of new inhibitors against this enzyme. Favorable and stereospecific interactions have been established in the S(1)' pocket for one of these inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures